Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

This document is a corrigendum published in the journal Frontiers in Psychiatry. It corrects an error in the author list of a previously published article titled "Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings." The corrected author list is provided, and the authors apologize for the error. The corrigendum does not affect the scientific conclusions of the original article. [Extracted from the article]